                               SEQUENCE LISTING

<110> THERAPEUTICS BY DESIGN, LLC

<120> THERAPEUTIC COMBINATIONS OF TDFRPS AND ADDITIONAL AGENTS AND 
      METHODS OF USE FOR THE REVERSAL OF FIBROSIS

<130> 132033-00320

<140> PCT/US2022/020627
<141> 2022-03-16

<150> 63/161,613
<151> 2021-03-16

<160> 4     

<170> PatentIn version 3.5

<210> 1
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 1
Cys Tyr Phe Asp Asp Ser Ser Asn Val Leu Cys Lys Lys Tyr Arg Ser 
1               5                   10                  15      


<210> 2
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 2
Cys Tyr Phe Asp Asp Ser Ser Gln Val Ile Cys Lys Lys Tyr Arg Ser 
1               5                   10                  15      


<210> 3
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide

<400> 3
Cys Tyr Tyr Asp Asn Ser Ser Ser Val Leu Cys Lys Arg Tyr Arg Ser 
1               5                   10                  15      


<210> 4
<211> 16
<212> PRT
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      peptide


<220>
<221> MOD_RES
<222> (14)..(14)
<223> D-Tyr

<400> 4
Cys Tyr Tyr Asp Asn Ser Ser Ser Val Leu Cys Lys Arg Tyr Arg Ser 
1               5                   10                  15      


